The Precision Blog
100% sourced from leading minds on the front lines of research
Recent and Featured Posts
View all articles-
Read Considerations for Your Pre-IND Meeting With the FDA
-
Read Inside a CRO: Essential Insights from Medical Monitoring Inside a CRO: Essential Insights from Medical Monitoring
Read Streamlining Clinical Trials in an Age of Complexity: Insights from Sofia Baig Streamlining Clinical Trials in an Age of Complexity: Insights from Sofia Baig
Read Pros and Cons: Innovative Study Designs vs. Traditional FIH Pros and Cons: Innovative Study Designs vs. Traditional FIH
-
-
Read: Clinical Trial Landscape: Radiopharmaceuticals 
Clinical Trial Landscape: Radiopharmaceuticals
-
Read: Clinical Trial Landscape: Rare CNS 
Clinical Trial Landscape: Rare CNS
-
Read: Considerations for Your Pre-IND Meeting With the FDA 
Considerations for Your Pre-IND Meeting With the FDA
-
-
-
Read: Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development 
Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development
-
Read: Precision Medicine in Pediatrics: Biomarkers and Assay Development 
Precision Medicine in Pediatrics: Biomarkers and Assay Development
-
Read: Companion Diagnostics: Key Considerations for Registrational Studies and Effective Co-Development with Therapeutics 
Companion Diagnostics: Key Considerations for Registrational Studies and Effective Co-Development with Therapeutics
-
All articles
-
Read: Clinical Trial Landscape: Radiopharmaceuticals
Clinical Trial Landscape: Radiopharmaceuticals
-
Read: Clinical Trial Landscape: Acute Myeloid Leukemia (AML) 
Clinical Trial Landscape: Acute Myeloid Leukemia (AML)
-
Read: Clinical Trial Landscape: Breast Cancer 
Clinical Trial Landscape: Breast Cancer
-
Read: Clinical Trial Landscape: Cell Therapies 
Clinical Trial Landscape: Cell Therapies
-
Read: Clinical Trial Landscape: Non-small Cell Lung Cancer (NSCLC) 
Clinical Trial Landscape: Non-small Cell Lung Cancer (NSCLC)
-
Read: Driving Oncology Trial Execution with Novel Data-Driven Approaches to Site and Patient Identification 
Driving Oncology Trial Execution with Novel Data-Driven Approaches to Site and Patient Identification
-
Read: Next in Gene Therapy: Trends, Innovations, and Challenges 
Next in Gene Therapy: Trends, Innovations, and Challenges
-
-
Read: Increased Complexity and Therapeutic Combinations Pave the Way in Immuno-oncology 
Increased Complexity and Therapeutic Combinations Pave the Way in Immuno-oncology
-
Read: Streamlining Recruitment in Biomarker-driven Oncology and Rare Disease Studies 
Streamlining Recruitment in Biomarker-driven Oncology and Rare Disease Studies
